Preservation of clonal heterogeneity of the Pneumocystis carinii-specific CD4 T cell repertoire in HIV infected, asymptomatic individuals

Clinical and Experimental Immunology

Volumn 128, Issue 1, 2002, Pages 155-162

  Li Pira, G ^a   Fenoglio, D ^a   Bottone, L ^a   Terranova, P ^a   Pontali, E ^b   Caroli, F ^c   Seri, M ^c   Cailliez, J C ^d   Koopman, G ^f   Accolla, R ^e   Del Galdo, F ^g   Abbate, G ^g   De Palma, R ^g   Manca, F ^a,h  

^a Advanced Biotechnology Centre   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h ADVANCED BIOTECHNOLOGY CENTER   (Italy)

Author keywords

CD4 cells; HIV; Opportunistic infections; Pneumocystis carinii; T cell receptor spectratyping

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN SPECIFICITY; ARTICLE; CELL HETEROGENEITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CLONE; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MULTIGENE FAMILY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; PROGENY; SEROLOGY; SYMPTOM; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CLONAL DELETION; CLONE CELLS; GENES, T-CELL RECEPTOR BETA; HIV SEROPOSITIVITY; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; PNEUMOCYSTIS; PNEUMOCYSTIS INFECTIONS;

EID: 0036247985     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01799.x     Document Type: Article

References (52)

1. T-lymphocyte subpopulations in homosexual men
2. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders
3. Opportunistic infections
4. Immunity to intracellular bacteria
5. + cytotoxic T-cell responses during chronic viral infection
6. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
7. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
8. Viral dynamics in human immunodeficiency virus type 1 infection
9. + T cell homeostasis and function in advanced HIV disease
10. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
11. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
12. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
13. Antiviral effect and ex-vivo CD4 T cell proliferation in HIV-1 positive patients as a result of CD28 costimulation
14. Anti HIV genetic therapy of antigen specific human CD4 lymphocytes for adoptive immunotherapy of AIDS
15. P. carinii pneumonia
16. Pathogenesis and host response in P. carinii pneumonia
17. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat
18. T cell repertoire diversity and clonal expansion in normal and in clinical samples
19. Effect of antigen antibody ratio on macrophage uptake, processing and presentation to T cells of antigen complexed with polyclonal antibodies
20. In vitro systems in Pneumocystis research
21. Recognition of antigenic clusters of Candida albicans by T lymphocytes from HIV infected individuals
22. HIV envelope glycoprotein, antigen specific T cell response and soluble CD4
23. The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV
24. Repertoire breadth of human CD4 cells specific for primary (HIV gp120 and p66) and for secondary (PPD and tetanus toxoid) antigens
25. An experimentally validated panel of subfamily-specific oligonucleotide primers for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction
26. Interaction of S. aureus toxin superantigens with human T cells
27. Studies on the human T cell receptor alpha-beta variable region genes
28. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of thye recombined germ-line segments
29. A direct estimate of the human alphabeta T cell receptor diversity
30. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping
31. Restricted and conserved T-cell repertoires involved in allorecognition of class II major histocompatibility complex
32. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell expansions
33. T-lymphocyte responses to P. carinii in healthy and HIV positive individuals
34. Blastogenic responses to P. carinii among patients with HIV infection
35. The in vitro response of human lymphocytes to P. carinii antigens
36. Identification of antigens and antibodies specific for P. carinii
37. Monoclonal antibodies to P. carinii: Identification of specific antigens and characterization of antigenic differences between rat and human isolates
38. Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence
39. Diversity in the human T cell receptor beta chain
40. Molecular defects in TCRBV genes preclude thymic selection and limit the expressed TCR repertoire
41. + T-cell regeneration HIV-infected adults
42. T-cell antigen receptor genes and T-cell recognition
43. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
44. + repertoire during antiviral therapy
45. Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after one year of highly active antiretroviral therapy
46. Perturbation of CD4 and CD8 T cell repertoires during progression to AIDS and regulation of CD4 repertoire during antiretroviral therapy
47. Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis
48. A class I MHC-restricted recall response to a viral peptide is highly polyclonal despite stringent CDR3 selection: Implications for establishing memory T cell repertoires in 'real-world' conditions
49. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia
50. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1 infected patients treated with highly active antiretroviral therapy
51. + T cell responses associated with control of viremia
52. Genetically modified immunocompetent cells in HIV infection